Personalized profiles of antioxidant signaling pathway in patients with tuberculosis

J Microbiol Immunol Infect. 2022 Jun;55(3):405-412. doi: 10.1016/j.jmii.2021.07.004. Epub 2021 Jul 17.

Abstract

Background/purpose: The non-protein thiol glutathione is protective against infection by Mycobacterium tuberculosis (MTB) and, together with the transcription factor NRF2 (the nuclear factor erythroid 2-related factor 2), plays a crucial role in counteracting MTB-induced redox imbalance. Many genes implicated in the antioxidant response belong to the NRF2-signalling pathway, whose central role in the pathogenesis of tuberculosis (TB) has been recently proposed.

Methods: In this study, we measured GSH levels in blood of patients with active TB and analysed the individual NRF2-mediated redox profile, in order to provide additional tools for discriminating the pathologic TB state and addressing therapeutic interventions.

Results: Our findings show a systemic individual modulation of GSH and NRF2 signaling pathway in patients with TB, with a "personalized" induction of NRF2-target genes.

Conclusion: This study can provide useful tools to monitor the course of the infection and address patients' treatment.

Keywords: Glutathione; NRF2; Oxidative stress; Redox profile; Tuberculosis (TB) patients.

MeSH terms

  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Glutathione / genetics
  • Glutathione / metabolism
  • Humans
  • NF-E2-Related Factor 2* / genetics
  • NF-E2-Related Factor 2* / metabolism
  • Oxidative Stress / physiology
  • Signal Transduction
  • Tuberculosis* / drug therapy

Substances

  • Antioxidants
  • NF-E2-Related Factor 2
  • Glutathione